Driven by a 15.1% CAGR, rising oncology demands, and breakthrough hybrid imaging technologies, the sector presents lucrative ...
The second Society of Nuclear Medicine and Molecular Imaging (SNMMI) AI Summit, organized by the SNMMI AI Task Force, took ...
Molecularly targeted therapies are increasingly relevant in clinical oncology, as they enable the selective modulation of specific biologic targets—such as enzymes or receptors—by inhibiting or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results